🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬plasma miR371 expression to detect early relapse in patients with clinical stage I testicular germ cell tumors on surveillance. 🧬No false+ 🧬miR371 high specificity, PP and NP in detecting relapse of GCM 🧬Promising ! Lucia Nappi ASCO OncoAlert #ASCO23

Lucia Nappi presents further data using miR371 to detect relapse in stage 1 testicular germ cell tumors. Excellent specificity. SWOG S1823 ongoing and will hopefully show this is ready for use in our clinics. #ASCO23 #ASCO2023 #tscsm - Benjamin Garmezy Sarah Cannon Docs

Very interesting germ cell biomarker work presented by Lucia Nappi at #ASCO23. MicroRNA 371 is for real! Prostate Cancer Foundation SWOG Cancer Research Network ASCO

Fabulous to see #testicularcancer up at #ASCO23 GU orals, with an excellent summary by ⭐️ #mentor Ben Tran Peter Mac Cancer Centre. 💡Lucia Nappi presenting further data on miR-371 and its growing clinical utility as a marker of MRD - see also Abs TPS5100/5103/5104 (½)

Nice summary!

I echo DrBagrodia . Ben Tran did a wonderful job discussing miR371- molecular biology and surgical treatment in early stage testis cancer . Great section!

Thank you very much!!!

Amazing people, great group!!!

Thanks Zach Klaassen and UroToday.com for this interview! Exciting time in Testicular Cancer Craig Nichols Sia Daneshmand, M.D.

Monsters collage #pcfretreat23

Monsters collage 2 with picture! #pcfretreat23

#AUA24 Julian Chavarriaga - miRNA to detect GCT in small testicular masses (STMs) Rob Hamilton UroToday.com 📍n=65 STMs w/ pre-orch serum/plasm 📍med tumor size: 1.4 cm (IQR 0.9-1.9) 📍n=41 GCTs (67.5% sem, 32.5% NSGCT), 24 benign 📍AUCs 0.774-0.932, Spec 92.3-100%, Sens 67.5-85%

As usual, amazing work from ⁦Rob Hamilton⁩ team on microRNAS in the MRD setting! qPCR serum and plasma vs ddPCR. Critically important work! ⁦Matthew Murray⁩ ⁦Lucia Nappi⁩ ⁦João Lobo⁩ ⁦Lindsay Frazier⁩ ⁦Malignant Germ Cell International Consortium⁩

#ASCO24 ASCO BC Cancer Our Vancouver team - way to represent! 🙌 #NOYCIA Christine Simmons Lucia Nappi

Watch an analysis of top abstracts from #ASCO24 in #GU #Cancer with experts Dr. Christian Kollmannsberger, Lucia Nappi and Vishal Navani, MD. ow.ly/RYgF50SheRM #CHAARTED2 #TheMAST #EMBARK #CYCLONE2 #PSMAfore #CLEAR #KEYNOTE426 #IMmotion010 #GUCancer #MedOnc

Pleasure to talk to Lucia Nappi #christiankollmannsberger about our #GUoncology #prostatecancer #kidneycancer #bladdercancer highlights from #asco24 ASCO

What's the link between #miRNAs & treating GU tumours? Learn about the biomarkers & clinical app. in the mgmt. & f/u of renal, prostate, & germ-cell tumours in this new #UROwebinar. Register now 👉webinars.uroweb.org/EAU/webinars/1… Carmen Jerónimo João Lobo Lucia Nappi pas_rescigno

The testis cancer educational section at #ASCO2025 is going to be great! Come and attend! Hall D1 at 1:15 today June 2/2025. I am honoured to be part of this stellar panel: Dr Einhorn, Dr Haugnes, DrBagrodia

ASCO⁩ #testicularcancer session dripping with wisdom from the one and only Larry Einhorn ⁦Indiana University Department of Urology⁩ ⁦IU Simon Comprehensive Cancer Center⁩ ⁦Lucia Nappi ⁦UBCUrology⁩ #HegeHaugnes ⁦Nabil Adra⁩ ⁦Rana McKay, MD, FASCO⁩ ⁦UC San Diego Health Moores Cancer Center⁩ ⁦UCSD Urology⁩ Team effort!

Very excited to be part of this truly global, multidisciplinary effort behind the Testicular Cancer Lancet Seminar. A comprehensive, up-to-date review covering all aspects of care in testicular cancer. Rob Hamilton Lucia Nappi Ciara Conduit Alexandros Papachristofilou Testicular cancer